Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IMOS | CHRN |
|---|---|---|
| Price | $79.30 | $18.93 |
| Change today | ▲ 2.44% | ▲ 1.77% |
| Market cap | $2.78B | $2.76B |
| Return, 3 months | +20.4% | +8.0% |
| Return, year to date | +171.1% | +119.1% |
| Return, 1 year | +299.5% | +244.8% |
| P/E (TTM) | 38.6 | -52.6 |
| P/B | 3.5 | 15.3 |
| P/E percentile vs own 5y | – | 3rd |
| Dividend yield | 0.96% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | +69.0% |
| Analyst buy share | – | 100% |
| RSI (14) | 66 | 43 |
| 30-day volatility | 69.9% | 84.3% |
| Max drawdown, 1 year | -39.8% | -40.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
